Literature DB >> 26646651

Biophysical aspect of phosphatidylinositol 3-kinase and role of oncogenic mutants (E542K & E545K).

Namrata Kalsi1, Chandrasekhar Gopalakrishnan1, Vidya Rajendran1, Rituraj Purohit2.   

Abstract

Genetic variations in oncogenes can often promote uncontrolled cell proliferation by altering the structure of the encoded protein, thereby altering its function. The PI3KCA oncogene that encodes for p110α, the catalytic subunit of phosphatidylinositol 3-kinase (PI3K), is one the most frequently mutated oncogenes in humans. PI3K plays a pivotal role in cell division. PI3K consists of two subunits: the catalytic (p110α) and regulatory (p85α). The regulatory subunit usually controls the catalytic subunit and switches off the enzyme when not required. It is believed that mutations in PI3KCA gene can alter the control of p85α over p110α and can sustain p110α in a prolonged active state. This in turn results in uncontrolled cell division. In this study, we investigate the pathogenic role of two point mutations: E542K and E545K on p110α subunit and how they alter its binding with the regulatory subunit. Molecular interaction and molecular dynamic simulation analysis are performed to study the dynamic behaviour of native and mutant structures at atomic level. Mutant p110α showed less interaction with its regulatory partner p85α than the native did, due to its expanded and rigid structure. Our analysis clearly points out that the structural and functional consequences of the mutations could promote tumour proliferation.

Entities:  

Keywords:  PI3K; biological partner; molecular dynamics; regulatory partner

Mesh:

Substances:

Year:  2016        PMID: 26646651     DOI: 10.1080/07391102.2015.1127774

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  5 in total

1.  Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.

Authors:  Nan Jin; Bhumsuk Keam; Janice Cho; Michelle J Lee; Hye Ryun Kim; Hayarpi Torosyan; Natalia Jura; Patrick Ks Ng; Gordon B Mills; Hua Li; Yan Zeng; Zohar Barbash; Gabi Tarcic; Hyunseok Kang; Julie E Bauman; Mi-Ok Kim; Nathan K VanLandingham; Danielle L Swaney; Nevan J Krogan; Daniel E Johnson; Jennifer R Grandis
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

2.  Exploring the effect of nsSNPs in human YPEL3 gene in cellular senescence.

Authors:  Abhishek Singh; Mukesh Thakur; Sujeet Kumar Singh; Lalit Kumar Sharma; Kailash Chandra
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

3.  Structural Perturbations due to Mutation (H1047R) in Phosphoinositide-3-kinase (PI3Kα) and Its Involvement in Oncogenesis: An in Silico Insight.

Authors:  Jatin Sharma; Vijay Bhardwaj; Rituraj Purohit
Journal:  ACS Omega       Date:  2019-09-20

4.  Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer.

Authors:  Jing Jing Liu; Jung Yoon Ho; Hye Won Lee; Min Wha Baik; Oyoung Kim; Youn Jin Choi; Soo Young Hur
Journal:  Int J Mol Sci       Date:  2019-07-10       Impact factor: 5.923

5.  Insights into the mechanism of the PIK3CA E545K activating mutation using MD simulations.

Authors:  Hari Leontiadou; Ioannis Galdadas; Christina Athanasiou; Zoe Cournia
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.